Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
Kamada S, Sakamoto S, Kinoshita R, Zhao X, Kamasako T, Yamase R, Junryo R, Saito S, Sangjon P, Takei A, Yamada Y, Goto Y, Imamura Y, Iguchi T, Mizokami A, Suzuki H, Akakura K, Ichikawa T.
Kamada S, et al. Among authors: kamasako t.
Prostate. 2024 May;84(7):636-643. doi: 10.1002/pros.24679. Epub 2024 Feb 27.
Prostate. 2024.
PMID: 38413843